Smp30/Regucalcin Is A Direct Transcriptional Target Of Wnt Signaling In The Liver

gang zeng,karinejak bowen,satdarshan s monga
DOI: https://doi.org/10.1096/fasebj.23.1_supplement.741.14
2009-01-01
Abstract:TheWnt/β ‐catenin pathway plays an essential role in liver biology. It is critical to identify novel transcriptional targets of this pathway to enable us to understand the basis of some of the functions of this pathway. By analyzing livers from β‐catenin conditional knockout mice (KO), we identified regucalcin as a downstream target of β‐catenin‐TCF signaling in the liver. Regucalcin is a Ca 2+ binding protein that regulates Ca 2+ transport, oxidative stress, and vitamin C metabolism. Western blotting and immunohistochemistry demonstrated the presence of regucalcin protein in the cytosol and nucleus of wild‐type mouse livers at 1, 3, and 6 months; however, regucalcin expression was markedly diminished in KO. Also, higher regucalcin levels were observed in HepG2 (active β‐catenin) as compared to Hep3B (normal β‐catenin) hepatoma cells. Next, regucalcin promoter was analyzed and several TCF‐4/beta‐catenin binding sites were identified. Luciferase reporter assays using deletion mutants of regucalcin promoter identified the TCF4 binding consensus sequence at ‐163 to ‐157 site to be the important for full transcriptional activation. Also, ChIP assays demonstrate a direct interaction of β‐catenin and TCF4 with this area of regucalcin promoter. In conclusion, we have identified regucalcin as a direct target of β‐catenin in the liver and provide evidence of direct regulation of its gene expression by β‐catenin/TCF interactions.
What problem does this paper attempt to address?